Iron Deficiency and Raised Hepcidin in Idiopathic Pulmonary Arterial Hypertension
Christopher J. Rhodes(Centre for Human Genetics), Martin R. Wilkins(Hammersmith Hospital), J. Simon R. Gibbs(National Institutes of Health), Luke Howard(Imperial College Healthcare NHS Trust), John Wharton(Pfizer (United Kingdom)), Mark Busbridge(Imperial College Healthcare NHS Trust), Damien Ashby(Hammersmith Hospital), Εumorfia Kondili(University of Crete)
Cited by 259
Related Papers
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784
Regulation of Endothelial Constitutive Nitric Oxide Synthase Gene Expression in Endothelial Cells and In Vivo
|Circulation|2000|631
Basic Science of Pulmonary Arterial Hypertension for Clinicians
|Circulation|2010|488